Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  ACB | T.ACB.WS.U

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Post by RichyRich$on Sep 20, 2020 3:14am
481 Views
Post# 31588142

Quarter Report Theoretically Already Happened September 8

Quarter Report Theoretically Already Happened September 8They already gave the bad news of the write-down and missed earnings consensus. Its already priced in. Which is why Mr. Wall Street is gonna look for any excuse in the actual Sept. 22 quarter report to short squeeze the shorts. Wall Street will see more profit in busting the shorts and doubling this stock price versus trying to work it down slightly lower. Actually... after the negative news on September 8... I'm quite impressed it held ground pretty good for the 2 weeks to follow. Usually after bad news it only trends down for 2 weeks before a huge reversal to the upside to fill the gap to the upside. Especially with a high short float. I averaged in for an average around $9.00/share. I'm expecting a big pop Wednesday morning! Wall Street will look for some excuse to rally this! Some future guidance and new strategy the new CEO will most likely disclose.
<< Previous
Bullboard Posts
Next >>